Please enable Javascript
Niels van de Donk, MD, PhD
Articles by Niels van de Donk, MD, PhD
Niels van de Donk, MD, PhD, Discusses MajesTEC-1 Follow-Up Data on Teclistamab in Multiple Myeloma
Cecilia Brown
Myeloma
|
September 5, 2023
The study evaluated teclistamab in patients with relapsed or refractory multiple myeloma.
View More
T-Cell Redirecting Bispecific Antibodies for the Treatment of Multiple Myeloma
Niels van de Donk, MD, PhD
Myeloma
|
October 21, 2021
The LocoMMotion study provides real-world data on outcomes in triple-class exposed MM patients receiving standard of care.
Read More